Neurolief

Neurolief Develops Proprietary Digital Therapeutics Neurostimulation Technology for Treating Neurological and Neuropsychiatric Disorders Such as Migraine and Depression. While Medication Often Proves Ineffective and May Cause Short-Term and Long-Term Adverse Effects, Neurolief’s Devices Can Complement or Replace Drug Therapy. Neurolief’s Products Are Breakthrough Head-Worn Electronic Devices Designed to Simultaneously Modulate Major Neural Pathways in the Head, Thereby Influencing Brain Regions Involved in Pain, Emotion Control, and Regulation. These Devices Aim to Provide Hundreds of Millions of Patients Worldwide with Effective Treatment Without Side Effects.